30 October 2025
30 October 2025
European biotechs should leverage its innovation and collaborate with Asian manufacturing hubs to secure greater investment, say experts.
The Puerto Rico facility investment comes alongside Lilly鈥檚 construction of four 鈥渕ega sites鈥� in the US.
The partnership is the latest in a long line of AI-centric projects in drug discovery and development.
The new biotech Elevara plans to initiate Phase II testing of its lead candidate ELV001 as an add-on treatment for rheumatoid arthritis.
The deals come against a backdrop of sweeping trade and pricing policies from Trump鈥檚 administration.
In a placebo-controlled, randomised Phase Ib trial, the therapy demonstrated a 77% reduction in bacterial BSIs against placebo.
The ODD programme incentivises the development of medicines for conditions affecting fewer than 200,000 individuals in the US.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
